No abstract available
MeSH terms
-
Atherosclerosis / etiology
-
Atherosclerosis / immunology
-
Atherosclerosis / metabolism
-
Atherosclerosis / prevention & control
-
Biomarkers
-
Cardiovascular Diseases / epidemiology*
-
Cardiovascular Diseases / prevention & control
-
Diabetes Mellitus, Type 2 / epidemiology
-
Diabetes Mellitus, Type 2 / immunology
-
Female
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology*
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
-
Hypercholesterolemia / complications
-
Hypercholesterolemia / drug therapy*
-
Hypercholesterolemia / immunology
-
Hypercholesterolemia / metabolism
-
Immunoglobulin G / immunology
-
Immunoglobulin M / immunology
-
Inflammation
-
Lipid Peroxidation / drug effects*
-
Lipoproteins, LDL / immunology
-
Lipoproteins, LDL / metabolism
-
Male
-
Malondialdehyde / blood
-
Risk Factors
Substances
-
Biomarkers
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors
-
Immunoglobulin G
-
Immunoglobulin M
-
Lipoproteins, LDL
-
oxidized low density lipoprotein
-
Malondialdehyde